Quick Takeaways
- Logos Global Management LP filed SCHEDULE 13G/A for CRESCENT BIOPHARMA, INC. Ordinary Shares (CBIO).
- Disclosed ownership: 4.1%.
- Date of event: 30 Jun 2025.
Logos Global Management LP - 30 Jun 2025 SCHEDULE 13G/A Report for CRESCENT BIOPHARMA, INC. Ordinary Shares (CBIO)
- Filing Manager
- Logos Global Management LP
- Reporting Manager
- Logos Global Management LP
- Symbol
- CBIO
- Shares outstanding
- 14,024,390 shares
- Disclosed Ownership
- 575,000 shares
- Ownership
- 4.1%
- Form type
- SCHEDULE 13G/A
- Filing time
- 14 Aug 2025, 14:24:39 UTC
- Date of event
- 30 Jun 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Logos Global Management LP disclosed 4.1% ownership in CRESCENT BIOPHARMA, INC. Ordinary Shares (CBIO) on 30 Jun 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 14 Aug 2025, 14:24.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (5)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Logos Global Management LP | 4.1% | 575,000 | 0 | 575,000 | Arsani William | Managing Partner | |
| Logos Global Management GP LLC | 4.1% | 575,000 | 0 | 575,000 | /s/ Arsani William | Managing Member | |
| Logos Global Master Fund LP | 0.7% | 100,000 | 0 | 100,000 | /s/ Arsani William | Managing Member of Logos GP LLC, General Partner of Logos Global Master Fund LP | |
| Logos GP LLC | 0.7% | 100,000 | 0 | 100,000 | /s/ Arsani William | Managing Member | |
| Arsani William | 4.1% | 575,000 | 0 | 575,000 | /s/ Arsani William | Reporting person |